Skip to main content Accessibility help

Parthenogenetic activation and somatic cell nuclear transfer of porcine oocytes activated by an electric pulse and AZD5438 treatment

  • Xiao-Chen Li (a1), Qing Guo (a1), Hai-Ying Zhu (a1), Long Jin (a1), Yu-Chen Zhang (a1), Guang-Lei Zhang (a1), Xiao-Xu Xing (a1), Mei-Fu Xuan (a1), Qi-Rong Luo (a1), Zhao-Bo Luo (a1), Jun-Xia Wang (a1), Cheng-Du Cui (a1), Wen-Xue Li (a1), Zheng-Yun Cui (a1), Xi-Jun Yin (a2) and Jin-Dan Kang (a2)...


We examined the in vitro developmental competence of parthenogenetic activation (PA) oocytes activated by an electric pulse (EP) and treated with various concentrations of AZD5438 for 4 h. Treatment with 10 µM AZD5438 for 4 h significantly improved the blastocyst formation rate of PA oocytes in comparison with 0, 20, or 50 µM AZD5438 treatment (46.4% vs. 34.5%, 32.3%, and 24.0%, respectively; P < 0.05). The blastocyst formation rate was higher in the group treated with AZD5438 for 4 h than in the groups treated with AZD5438 for 2 or 6 h (42.8% vs. 38.6% and 37.2%, respectively; P > 0.05). Furthermore, 66.67% of blastocysts derived from these AZD5438-treated PA oocytes had a diploid karyotype. The blastocyst formation rate of PA and somatic cell nuclear transfer (SCNT) embryos was similar between oocytes activated by an EP and treated with 2 mM 6-dimethylaminopurine for 4 h and those activated by an EP and treated with 10 µM AZD5438 for 4 h (11.11% vs. 13.40%, P > 0.05). In addition, the level of maturation-promoting factor (MPF) was significantly decreased in oocytes activated by an EP and treated with 10 µM AZD5438 for 4 h. Finally, the mRNA expression levels of apoptosis-related genes (Bax and Bcl-2) and pluripotency-related genes (Oct4, Nanog, and Sox2) were checked by RT-PCR; however, there were no differences between the AZD5438-treated and non-treated control groups. Our results demonstrate that porcine oocyte activation via an EP in combination with AZD5438 treatment can lead to a high blastocyst formation rate in PA and SCNT experiments.


Corresponding author

All correspondence to: Jin-Dan Kang or Xi-Jun Yin. Jilin Provincial Key Laboratory of Transgenic Animal and Embryo Engineering, Yanbian University, Yanji, Jilin, 133002, China. Tel: +86 0433 2435623. Fax: +86 0433 2435622. E-mail: or


Hide All

These authors contributed equally to this study.



Hide All
Arias, M.E., Sánchez, R. & Felmer, R. (2016). Effect of anisomycin, a protein synthesis inhibitor, on the in vitro developmental potential, ploidy and embryo quality of bovine ICSI embryos. Zygote 24, 724–32.
Bos-Mikich, A., Bressan, F.F., Ruggeri, R.R., Watanabe, Y. & Meirelles, F.V. (2016). Parthenogenesis and human assisted reproduction. Stem Cells Int. 2016, 1970843.
Byth, K.F., Thomas, A., Hughes, G., Forder, C., McGregor, A., Geh, C., Oakes, S., Green, C., Walker, M., Newcombe, N., Green, S., Growcott, J., Barker, A. & Wilkinson, R.W. (2009). AZD5438, a potent oral inhibitor of cyclin-dependent kinases 1, 2, and 9, leads to pharmacodynamic changes and potent antitumor effects in human tumour xenografts. Mol. Cancer Ther. 8, 1856–66.
Camidge, D.R., Pemberton, M., Growcott, J., Amakye, D., Wilson, D., Swaisland, H., Forder, C., Wilkinson, R., Byth, K. & Hughes, A. (2007a). Phase I pharmacodynamic study of the effects of the cyclin-dependent kinase-inhibitor AZD5438 on cell cycle markers within the buccal mucosa, plucked scalp hairs and peripheral blood mononucleocytes of healthy male volunteers. Cancer Chemother. Pharmacol. 60, 479–88.
Camidge, D.R., Smethurst, D., Growcott, J., Barrass, N.C., Foster, J.R., Febbraro, S., Swaisland, H. & Hughes, A. (2007b). A first-in-man phase I tolerability and pharmacokinetic study of the cyclin-dependent kinase-inhibitor AZD5438 in healthy male volunteers. Cancer Chemother. Pharmacol. 60, 391–8.
Cha, S.K., Kim, N.H., Lee, S.M., Baik, C.S., Lee, H.T. & Chung, K.S. (1997). Effect of cytochalasin B and cycloheximide on the activation rate, chromosome constituent and in vitro development of porcine oocytes following parthenogenetic stimulation. Reprod. Fertil. Dev. 9, 441–6.
De La Fuente, R. & King, W.A. (1998). Developmental consequences of karyokinesis without cytokinesis during the first mitotic cell cycle of bovine parthenotes. Biol. Reprod. 58, 952–62.
Diao, Y.F., Naruse, K., Li, X.X., Han, R.X., Kim, D.K., Lin, T. & Jin, D.I. (2013). Effects of 5-aza-2´-deoxyctidine on the development of porcine parthenogenetic and nuclear transfer embryos. Nat. Sci. 5, 3137.
Dinnyés, A., Hirao, Y. & Nagai, T. (2000). Parthenogenetic activation of porcine oocytes by electric pulse and/or butyrolactone I treatment. Cloning 1, 209–16.
Fukui, Y., Sawai, K., Furudate, M., Sato, N., Iwazumi, Y. & Ohsaki, K. (1992). Parthenogenetic development of bovine oocytes treated with ethanol and cytochalasin B after in vitro maturation. Mol. Reprod. Dev. 33, 357–62.
Hashimoto, N. & Kishimoto, T. (1988). Regulation of meiotic metaphase by a cytoplasmic maturation promoting factor during mouse oocytes maturation. Dev. Biol. 126, 242–52.
Lee, H.S., Kim, K.H., Kim, E.Y., Lee, S.Y., Ko, J.J. & Lee, K.A. (2016). Obox4-silencing-activated STAT3 and MPF/MAPK signaling accelerate nuclear membrane breakdown in mouse oocytes. Reproduction 151, 369–78.
Lee, J., Park, J.I., Yun, J.I., Lee, Y., Yong, H., Lee, S.T., Park, C.K., Hyun, S.H., Lee, G.S. & Lee, E. (2015). Rapamycin treatment during in vitro maturation of oocytes improves embryonic development after parthenogenesis and somatic cell nuclear transfer in pigs. J. Vet. Sci. 16, 373–80.
Lee, J.W., Tian, X.C. & Yang, X. (2004). Optimization of parthenogenetic activation protocol in porcine. Mol. Reprod. Dev. 68, 51–7.
Li, S., Kang, J.D., Jin, J.X., Hong, Y., Zhu, H.Y., Jin, L., Gao, Q.S., Yan, C.G., Cui, C.D., Li, W.X. & Yin, X.J. (2014). Effect of demecolcine-assisted enucleation on the MPF level and cyclin B1 distribution in porcine oocytes. PLoS One 9, e91483.
Liang, S., Zhao, M.H., Choi, J.W., Kim, N.H. & Cui, X.S. (2015). Scriptaid treatment decreases DNA methyltransferase 1 expression by induction of micriRNA-125 expression in porcine somatic cell nuclear transfer embryos. PLoS One 10, e0134567.
Liu, L., Ju, J.C. & Yang, X. (1998). Parthenogenetic development and protein patterns of newly matured bovine oocytes following chemical activation. Mol. Reprod. Dev. 49, 298307.
Masui, Y. (1991). The role of cytostatic factor (CSF) in the control of oocyte cell cycle – a summary of 20 years study. Dev. Growth Differ. 33, 543–51.
Masui, Y. & Markert, C.L. (1971). Cytoplasmic control of nuclear behavior during meiotic maturation of frog oocytes. J. Exp. Zool. 177, 129–45.
Mayes, M.A., Stogsdill, P.L. & Prather, R.S. (1995). Parthenogenic activation of pig oocytes by protein kinase inhibition. Biol. Reprod. 53, 270–5.
McGrath, J. & Solter, D. (1984). Completion of mouse embryogenesis requires both the maternal and paternal genomes. Cell 37, 179–83.
Nussbaum, D.J. & Prather, R.S. (1995). Differential effects of protein synthesis inhibitors on porcine oocyte activation. Mol. Reprod. Dev. 41, 70–5.
Presicce, G.A. & Yang, X. (1994). Parthenogenetic development of bovine oocytes matured in vitro for 24 hr and activated by ethanol and cycloheximide. Mol. Reprod. Dev. 38, 380–5.
Raghavan, P., Tumati, V., Yu, L., Chan, N., Tomimatsu, N., Burma, S., Bristow, R.G. & Saha, D. (2012). AZD5438, an inhibitor of Cdk1, 2, and 9, enhances the radiosensitivity of non-small cell lung carcinoma cells. Int. J. Radiat. Oncol. Biol. Phys. 84, e507–14.
Saikhun, J., Kitiyanant, N., Songtaveesin, C., Pavasuthipaisit, K. & Kitiyanant, Y. (2004). Development of swamp buffalo (Bubalus bubalis) embryos after parthenogenetic activation and nuclear transfer using serum fed or starved fetal fibroblasts. Reprod. Nutr. Dev. 44, 6578.
Sommer, C.A., Stadtfeld, M., Murphy, G.J., Hochedlinger, K., Kotton, D.N. & Mostoslavsky, G. (2009). Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells 27, 543–9.
Surani, M.A. & Barton, S.C. (1983). Development of gynogenetic eggs in the mouse: implications for parthenogenetic embryos. Science 222, 1034–6.
Van De Velde, A., Liu, L., Bols, P.E., Ysebaert, M.T. & Yang, X. (1999). Cell allocation and chromosomal complement of parthenogenetic and IVF bovine embryos. Mol. Reprod. Dev. 54, 5762.
Wang, H.Y., Luo, Y.B., Lin, Z.L., Lee, I.W., Kwon, J., Cui, X.S. & Kim, N.H. (2015). Effect of ATM and HDAC inhibition on etoposide-induced DNA damage in porcine early preimplantation embryos. PLoS One 10, e0142561.
Whitworth, K.M., Li, R.F., Spate, L.D., Wax, D.M., Rieke, A., Whyte, J.J., Manandhar, G., Sutovsky, M., Green, J.A., Sutovsky, P. & Prather, R. (2009). Method of oocyte activation affects cloning efficiency in pigs. Mol. Reprod. Dev. 76, 490500.
Yang, M.Y. & Rajamahendran, R. (2002). Expression of Bcl-2 and BAX proteins in relation to quality of bovine oocytes and embryos produced in vitro . Anim. Reprod. Sci. 70, 159–69.
Yin, X.J., Tani, T., Yonemura, I., Kawakami, M., Miyamoto, K., Hasegawa, R., Kato, Y. & Tsunoda, Y. (2002). Production of cloned pigs from adult somatic cells by chemically assisted removal of maternal chromosomes. Biol. Reprod. 67, 442–6.
Zhang, D.X., Park, W.J., Sun, S.C., Xu, Y.N., Li, Y.H., Cui, X.S. & Kim, N.H. (2011). Regulation of maternal gene expression by MEK/MAPK and MPF signaling in porcine oocytes during in vitro meiotic maturation. J. Reprod. Dev. 57, 4956.
Zhao, M.H., Kim, N.H. & Cui, X.S. (2016). GlutaMAX prolongs the shelf life of the culture medium for porcine parthenotes. Theriogenology 85, 368375.


Related content

Powered by UNSILO

Parthenogenetic activation and somatic cell nuclear transfer of porcine oocytes activated by an electric pulse and AZD5438 treatment

  • Xiao-Chen Li (a1), Qing Guo (a1), Hai-Ying Zhu (a1), Long Jin (a1), Yu-Chen Zhang (a1), Guang-Lei Zhang (a1), Xiao-Xu Xing (a1), Mei-Fu Xuan (a1), Qi-Rong Luo (a1), Zhao-Bo Luo (a1), Jun-Xia Wang (a1), Cheng-Du Cui (a1), Wen-Xue Li (a1), Zheng-Yun Cui (a1), Xi-Jun Yin (a2) and Jin-Dan Kang (a2)...


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.